Jailed psychiatrist pleads guilty
A psychiatrist involved in two clinical trials evaluating the drug Paxil's safety and effectiveness in children and adolescents has pleaded guilty to 15 federal counts of failing to prepare and maintain records, with intent to defraud and mislead, in connection with those clinical trials.
Dr. Maria Carmen Palazzo was a clinical investigator for SmithKline Beecham doing business as GlaxoSmithKline.
Prosecutors say that during those studies she included psychiatric diagnoses inconsistent with patients' psychiatric histories; prepared multiple psychiatric evaluations on study patients which contained different diagnoses and reported symptoms she knew the study subject did not demonstrate.
She was sentenced to 13 months in prison and will run at the same time as her current 87-month prison term for health care fraud.